Patent classifications
A61B2503/045
Systems and methods for magnetic resonance imaging of infants
According to some aspects, a system configured to facilitate imaging an infant using a magnetic resonance imaging (MRI) device is provided herein. The system comprises an infant-carrying apparatus comprising an infant support configured to support the infant and an isolette for positioning the infant relative to the MRI device, the isolette comprising: a base for supporting the infant-carrying apparatus; and a bottom surface configured to be coupled to the MRI device. In some embodiments, the infant-carrying apparatus further comprises at least one radio frequency (RF) coil coupled to the infant support and configured to be coupled to the MRI device to detect MR signals during imaging performed by the MRI device. A method for positioning an infant relative to an MRI device using an infant-carrying apparatus and isolette is further provided herein.
JAUNDICE DIAGNOSIS AND TREATMENT SYSTEM AND COMPUTER-READABLE STORAGE MEDIUM
A jaundice diagnosis and treatment system includes a control circuit, a bilirubin measurement assembly, a risk evaluation circuit and a display assembly, wherein the bilirubin measurement assembly is communicatively connected to the control circuit, and is used for measuring a bilirubin concentration of a newborn baby and transmitting the measured bilirubin concentration to the control circuit, so that the control circuit generates measurement data according to the measured bilirubin concentration; the risk evaluation circuit is communicatively connected to the control circuit, and is used for acquiring the measurement data from the control circuit and evaluating a pathologic jaundice risk level according to the measurement data; and the display assembly is connected to the control circuit, and is used for displaying the measurement data and/or the pathologic jaundice risk level under the control of the control circuit.
Use of Glucose Control Indicators for Risk Assessment and Treatment of Neurodevelopmental Disorders and Techniques for Establishing the Status of Chronic Glucose Control
Dysglycemia as a risk factor for neurodevelopmental disorder or developmental diabetes. The risk is assessed based on measurement of a glucose control indicator in a blood sample. One particular example of a neurodevelopmental disorder is retinopathy of prematurity in an infant. One particular example of a glucose control indicator is ‘comprehensive glycated hemoglobin fraction’ or ‘comprehensive glycated albumin fraction.’ This is calculated using ‘total whole blood protein’ in the denominator. In the case of chronic hyperglycemia, there is an increased risk of proliferative retinopathy of prematurity. In the case of chronic hypoglycemia, there is an increased risk of non-proliferative retinopathy of prematurity. This ‘total whole blood protein’ technique could also be used to determine the glucose control status in other types of patients.
MEASURING AND/OR CHARACTERIZING FEEDING BEHAVIOR
A feeding analysis system reviews collected feeding data and provides analysis of data regarding nutritive sucking, feeding, and related activity.
Dual Mode Non-Invasive Blood Pressure Management
The present specification describes methods and systems for on-inflate non-invasive blood pressure (NIBP) measurement suitable for cuffs of various sizes. In embodiments, an adapter hose connecting the cuff to the NIBP device is dynamically identified. Embodiments provide a restriction in at least one of the valves in the NIBP device to enable a controlled release of air from the device during the cuff inflation process.
VISION-BASED PATIENT STIMULUS MONITORING AND RESPONSE SYSTEM AND METHOD UTILIZING VISUAL IMAGES
Vision-based stimulus monitoring and response systems and methods are presented, wherein detection, via image(s) of a patient through an external stimulus, such as a caregiver, prompts analysis of the response of the patient, via secondary patient sensors or via analysis of patient image(s), to determine an autonomic nervous system (ANS) state.
INTELLIGENT SCREENING ALGORITHM AND AUTOMATIC UPGRADING SYSTEM FOR CONGENITAL HEART DISEASES OF NEWBORNS BASED ON BIG DATA
The present disclosure discloses an intelligent screening algorithm and automatic upgrading system for congenital heart diseases of newborns based on big data. The key point of the technical solution is as follows: The intelligent screening algorithm and automatic upgrading system includes a heart sound data module, a heart sound data processing module, a blood oxygen data module, a blood oxygen data processing module, a network upgrading module, a database, an intelligent analysis module and a congenital heart disease evaluation module; the heart sound data module is configured to acquire various data of heart sounds of a newborn for centralized processing; and the heart sound data processing module is configured to process the data in the heart sound data module and extract heart sound feature parameters.
DEVICE AND METHOD FOR SCREENING CONGENITAL HEART DISEASE
An apparatus including a main processing unit. The apparatus further including a precordial patch coupled to the main processing unit, the precordial patch having a plurality of sensors for detecting heart sounds and cardiac electrical signals (ECG). The apparatus further including a probe coupled to the main processing unit, the probe having a sensor for detecting oxygen saturation of blood circulating through a human. A method is further described including simultaneously measuring and analyzing heart sounds, cardiac electrical signals (ECG) and oxygen saturation of blood circulating through a human. The method further includes performing an algorithm to determine the presence of a significant congenital heart disease and displaying management recommendations based on results of the algorithm.
System and method for skin detection of a human subject
The present invention relates to a system and method of skin detection of a human subject using a textile product. The textile product (10, 31, 43) is made from or comprising textile including near-infrared, NIR, absorbing pigments. It supports and/or partially covers the human subject while skin detection and/or detection/monitoring vital signs of the human subject is carried out. A increased contrast between the textile product and skin in the NIR wavelength range is thus achieved.
Alarm system for intravenous pump or catheter based upon fuzzy logic
In some embodiments, a self-monitoring intravenous catheter system is provided. An alarm controller is provided that receives signals representing a pH value, an oxygen saturation value, and a pressure value in proximity to the distal end of the catheter. By performing a fuzzy logic analysis of the values, the alarm controller is able to detect that the catheter is about to fail or has failed, and can cause alerts to be presented. In some embodiments, an intravenous catheter is provided that has a pH sensor and an oximeter disposed at a distal end of the catheter to obtain the pH value and oxygen saturation values analyzed by the alarm controller. Embodiments of the catheter and self-monitoring intravenous catheter system may be particularly useful in treating neonates, who are sensitive to catheter failure and are not capable of detecting the signs of failure themselves.